Use of Somanetics’ INVOS Cerebral Oximeter Significantly Decreased Stroke Rate and Adverse Clinical Outcomes
Somanetics Corporation (Nasdaq: SMTS, news) today announced that the results of the first randomized, prospective and blinded study using the Company’s INVOS® […]
Hydroxyethyl Starch as a Priming Solution for Impairs Hemostasis After Cardiac Surgery
Abstract: We investigated the influence of hydroxyethyl starch (HES) as a priming solution for the cardiopulmonary bypass (CPB) circuit on postoperative hemostasis […]
Summary of the Anti-Referral Stark Amendment (A Stark Remider to Physicians)
Sec. 1395nn. Limitation on certain physician referrals. (a) Prohibition of certain referrals. (1) In general. Except as provided in subsection (b) of […]
Statin Use Appears to Enhance Coronary Collateral Formation
Collateralization of severely diseased coronary arteries is greater in patients on statin therapy than in those who are not, researchers report. As […]
Stem Cells May Eliminate Need for Heart Transplant In Some Patients
Four out of a group of five seriously sick Brazilian heart-failure patients no longer needed a heart transplant after being treated with […]
Heart Stents Have Better Outcome than Balloon Angioplasty in Diabetics
In diabetic patients, coronary stent implantation results in a better six-month angiographic outcome and four-year clinical events compared with standard balloon angioplasty. […]
Randomized Comparison Between Stenting and Off-Pump Bypass Surgery in Patients Referred for Angioplasty
Background Stenting improves cardiac outcome in comparison with balloon angioplasty. Compared with conventional surgery, off-pump bypass surgery on the beating heart without […]
Stenting and Minimally Invasive Bypass Surgery Equally Effective for Isolated High-grade Lesions
Minimally invasive bypass surgery and coronary stenting are equally effective in managing patients with isolated high-grade lesions of the proximal left anterior […]
Primary Stenting More Costly Over the Long Term than CABG or PTCA
NEW YORK (Reuters Health) – The estimated long-term costs of primary stenting in patients with multivessel coronary disease appear to be higher […]
FDA Approves Sirolimus-eluting Coronary Stent
The U.S. Food and Drug Administration said on Thursday that it has cleared for marketing Johnson & Johnson’s Cypher sirolimus-coated stent for […]
Boston Scientific to Reveal Key Heart Stent Data
After months of playing it close to the vest, Boston Scientific Corp. will show its cards next week when it unveils results […]
Ventricular-Coronary Conduit Device Developed in Germany
BERLIN (Reuters Health) -The days of the traditional coronary artery bypass graft could be numbered, with the introduction of a device developed […]